Phase 2 Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who have had an acute ischaemic stroke (a stroke caused by a blockage) involving two connected blockages — one in a blood vessel inside the brain and one in the main artery in the neck, where the neck blockage is thought to be caused by fatty buildup in the artery walls
- People whose brain scan results show a meaningful amount of brain tissue that may still be saved, based on specific measurements of the affected area (confirm with trial site for exact scan thresholds)
- People with at least a mild level of stroke-related neurological impairment, as measured by a standard medical scoring scale (confirm with trial site)
- People who were largely independent in daily life before their stroke, based on a standard disability rating scale (confirm with trial site)
Who may not be able to join:
- People considered unlikely to benefit from the study treatment, including those with advanced dementia, severe disability before their stroke, a very low level of consciousness, or a large area of already-damaged brain tissue
- People with severely high blood pressure that has not responded to treatment
- People who have had bleeding inside the brain within the last 90 days
- People who have had a heart attack or stroke within the last 30 days
- People with an existing illness where life expectancy is less than 90 days
- People known to be taking blood-thinning (anticoagulant) medications
- People with known severe liver disease
- People with a known bleeding disorder
- People who have had CPR, a needle inserted into a site where pressure cannot be applied to stop bleeding, or a lumbar puncture within the last 7 days
- People with another medical condition or personal circumstance that may interfere with follow-up assessments
- People who are known or suspected to be pregnant
- People currently taking part in another interventional clinical trial
- People for whom informed consent cannot be obtained from themselves or their authorised decision-maker before the study procedures begin
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ferdinand Miteff - Interventional Neurologist, RACP, CCINR, John Hunter Hospital, Newcastle, NSW Australia
Phone: 612 4921 3490
Australian sites
+61299267111
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Proportion of patients achieving a composite outcome of efficacy and safety
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.